Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia

被引:30
作者
Endeman, Henrik [1 ]
Schelfhout, Vanessa
Voorn, G. Paul [2 ]
Van Velzen-Blad, Heleen [2 ]
Grutters, Jan C.
Biesma, Douwe H. [3 ]
机构
[1] Onze Lieve Vrouw Hosp, Dept Intens Care Med, NL-1090 HM Amsterdam, Netherlands
[2] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands
[3] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands
关键词
D O I
10.1080/00365540802014864
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Community acquired pneumonia (CAP) is caused by a variety of microorganisms. By identifying patients at risk for failure of pathogen identification, it is possible to make an early decision on the extent of diagnostic procedures to be performed. This is especially important in patients with severe CAP. The aim of this study was to identify these patients by using clinical and laboratory features. In 201 patients hospitalized for CAP, clinical and laboratory variables were collected. Pathogen identification was performed by culture of sputum and blood, urine antigen tests, polymerase chain reaction of sputum, serological testing and viral culture of the pharynx. In 128 patients a respiratory microorganism was identified. In both univariate and multivariate analysis, failure of pathogen identification was predicted by pre-hospital antibiotic therapy, a medical history of hypertension and a low C-reactive protein. We conclude that patients with pre-hospital antibiotic therapy, a medical history of hypertension and a relatively low C-reactive protein are at risk for failure of pathogen identification. These predictors should be confirmed in a larger population. Invasive testing in high-risk patients with CAP in the presence of these predictors should be considered at an early phase of hospitalization.
引用
收藏
页码:715 / 720
页数:6
相关论文
共 17 条
[1]
Epidemiology of community-acquired pneumonia in adults:: a population-based study [J].
Almirall, J ;
Bolíbar, I ;
Vidal, J ;
Sauca, G ;
Coll, P ;
Niklasson, B ;
Bartolomé, M ;
Balanzo, X .
EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (04) :757-763
[2]
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[3]
ETIOLOGY OF COMMUNITY-ACQUIRED PNEUMONIA - A PROSPECTIVE-STUDY AMONG ADULTS REQUIRING ADMISSION TO HOSPITAL [J].
BOHTE, R ;
VANFURTH, R ;
VANDENBROEK, PJ .
THORAX, 1995, 50 (05) :543-547
[4]
Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study [J].
Etminan, M ;
Zhang, B ;
FitzGerald, M ;
Brophy, JM .
PHARMACOTHERAPY, 2006, 26 (04) :479-482
[5]
Community-acquired pneumonia [J].
File, TM .
LANCET, 2003, 362 (9400) :1991-2001
[6]
Do smoking parents seek the best advice for their asthmatic children? [J].
Friend, JAR .
THORAX, 2001, 56 (01) :1-1
[7]
Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial Legionnaires' disease [J].
Helbig, JH ;
Uldum, SA ;
Bernander, S ;
Lück, PC ;
Wewalka, G ;
Abraham, B ;
Gaia, V ;
Harrison, TG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) :838-840
[8]
Real-time PCR assay targets the 23S-5S spacer for direct detection and differentiation of Legionella spp. and Legionella pneumophila [J].
Herpers, BL ;
de Jongh, BM ;
van der Zwaluw, K ;
van Hannen, EJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) :4815-4816
[9]
Guidelines for community-acquired pneumonia: A tale of 2 countries [J].
Mandell, LA .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :422-425
[10]
Epidemiology and etiology of community-acquired pneumonia [J].
Mandell, LA .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2004, 18 (04) :761-+